日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Urinary clusterin as a biomarker of human kidney disease progression and response to the endothelin receptor antagonist atrasentan: An exploratory analysis from the SONAR trial.

尿簇蛋白作为人类肾脏疾病进展和对内皮素受体拮抗剂阿曲生坦反应的生物标志物：来自 SONAR 试验的探索性分析。

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-026-68973-5
Ju Wenjun, Nair Viji, Vart Priya, Smeijer J David, Hudkins Kelly L, Moedt Erik, Larkina Maria, Perco Paul, Burdet Frédéric, Shedden Kerby, Hwang Michael, Lee Edmond, O'Connor Christopher, Hartman John, Subramanian Lalita, Bitzer Markus, Ibberson Mark, Duffin Kevin L, Gomez Maria F, Alpers Charles E, Kretzler Matthias, Heerspink Hiddo J L
Human
发表日期：2026
文献求助 收藏

Computational Drug Repositioning in Cardiorenal Disease: Opportunities, Challenges, and Approaches

心肾疾病中的计算药物重定位：机遇、挑战与方法

期刊:Proteomics
影响因子:3.9
doi:10.1002/pmic.202400109
Perco, Paul; Ley, Matthias; Kęska-Izworska, Kinga; Wojenska, Dorota; Bono, Enrico; Walter, Samuel M; Fillinger, Lucas; Kratochwill, Klaus
发表日期：2025
文献求助 收藏

Investigation of the Urinary Peptidome to Unravel Collagen Degradation in Health and Kidney Disease

通过研究尿液肽组学揭示健康和肾脏疾病中胶原蛋白的降解机制

期刊:Proteomics
影响因子:
doi:10.1002/pmic.202400279
Mina, Ioanna K; Iglesias-Martinez, Luis F; Ley, Matthias; Fillinger, Lucas; Perco, Paul; Siwy, Justyna; Mischak, Harald; Jankowski, Vera
发表日期：2025
文献求助 收藏

The Omics-Driven Machine Learning Path to Cost-Effective Precision Medicine in Chronic Kidney Disease

组学驱动的机器学习在慢性肾病精准医疗中的应用：一种经济高效的治疗方法

期刊:Proteomics
影响因子:
doi:10.1002/pmic.202400108
Lopes, Marta B; Coletti, Roberta; Duranton, Flore; Glorieux, Griet; Jaimes Campos, Mayra Alejandra; Klein, Julie; Ley, Matthias; Perco, Paul; Sampri, Alexia; Tur-Sinai, Aviad
发表日期：2025
文献求助 收藏

Non-adherence to cardiometabolic medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus

通过尿液液相色谱-串联质谱法评估2型糖尿病患者对心血管代谢药物的依从性及其与肾脏和心血管结局的关系

期刊:Diabetologia
影响因子:10.2
doi:10.1007/s00125-024-06149-w
Denicolò, Sara; Reinstadler, Vera; Keller, Felix; Thöni, Stefanie; Eder, Susanne; Heerspink, Hiddo J L; Rosivall, László; Wiecek, Andrzej; Mark, Patrick B; Perco, Paul; Leierer, Johannes; Kronbichler, Andreas; Oberacher, Herbert; Mayer, Gert
糖尿病
代谢
发表日期：2024
文献求助 收藏

OntoloViz: a GUI for interactive visualization of ranked disease or drug lists using the MeSH and ATC ontologies

OntoloViz：一个使用 MeSH 和 ATC 本体对疾病或药物列表进行排序的交互式可视化的图形用户界面

期刊:Bioinformatics Advances
影响因子:2.8
doi:10.1093/bioadv/vbad113
Ley, Matthias; Heinzel, Andreas; Fillinger, Lucas; Kratochwill, Klaus; Perco, Paul
发表日期：2023
文献求助 收藏

Assessment of Fibrinogen-like 2 (FGL2) in Human Chronic Kidney Disease through Transcriptomics Data Analysis

通过转录组学数据分析评估人类慢性肾脏病中纤维蛋白原样蛋白2 (FGL2) 的表达

期刊:Biomolecules
影响因子:4.8
doi:10.3390/biom13010089
Denicolò, Sara; Nair, Viji; Leierer, Johannes; Rudnicki, Michael; Kretzler, Matthias; Mayer, Gert; Ju, Wenjun; Perco, Paul
Human
发表日期：2022
文献求助 收藏

Coregulation Analysis of Mechanistic Biomarkers in Autosomal Dominant Polycystic Kidney Disease.

常染色体显性多囊肾病机制生物标志物的共调控分析

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms22136885
Leierer Johannes, Perco Paul, Hofer Benedikt, Eder Susanne, Dzien Alexander, Kerschbaum Julia, Rudnicki Michael, Mayer Gert
其它
发表日期：2021
文献求助 收藏

Predictive Biomarkers in Nephrology Around the Corner

肾脏病预测性生物标志物即将问世

期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2019.10.009
Perco, Paul; Sharma, Kumar
发表日期：2020
文献求助 收藏

Multimarker Panels in Diabetic Kidney Disease: The Way to Improved Clinical Trial Design and Clinical Practice?

糖尿病肾病多标志物检测：改善临床试验设计和临床实践的途径？

期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2018.12.001
Perco, Paul; Pena, Michelle; Heerspink, Hiddo J L; Mayer, Gert
糖尿病
糖尿病肾病
代谢
发表日期：2019
文献求助 收藏